Pharmacokinetics (PK)

项目摘要/摘要(药代动力学) 药代动力学(PK)共享资源(SR)成立于2009年，由CCSG资助 自2012年以来。PK SR的目标是提供高质量、低成本和高效率的服务，以推动 癌症研究取得进展。它使用与密歇根大学综合癌症大学一对一的咨询 该中心(UMCCC)成员在项目开始时鼓励创新研究并支持 多学科协作。SR已成功地在能力、服务和人员配备方面进行了增长，以便 与不断扩大的用户群保持同步。自成立以来，PK SR一直由孙杜新博士领导， 熟练的研究员，在临床前和临床PK和药物开发方面有丰富的经验。通过工作 孙博士和他的团队与UMCCC的领导和成员密切合作，预见到 UMCCC的研究人员通过采用最先进的技术和方法，加快了 成员研究引发的新型抗癌治疗药物的发展。

PROJECT SUMMARY/ABSTRACT (PHARMACOKINETICS) The Pharmacokinetics (PK) Shared Resource (SR) was founded in 2009 and has been funded by the CCSG since 2012. The goal of the PK SR is to provide high quality, cost- and time-efficient services that propel cancer research forward. It uses one-on-one consultations with University of Michigan Comprehensive Cancer Center (UMCCC) members at the start of projects to stimulate innovative research and to support multidisciplinary collaborations. The SR has successfully grown in capability, services, and staffing in order to keep pace with an expanding user base. Since its inception, the PK SR has been led by Duxin Sun, PhD, a skilled investigator with extensive experience in preclinical and clinical PK and drug development. By working closely with UMCCC leaders and members, Dr. Sun and his team have anticipated the changing needs of UMCCC researchers by adopting state-of-the-art technologies and approaches that accelerate the development of novel anticancer therapeutics arising from member research.